{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "34227076",
  "DateCompleted": {
    "Year": "2021",
    "Month": "07",
    "Day": "14"
  },
  "DateRevised": {
    "Year": "2021",
    "Month": "11",
    "Day": "29"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.26355/eurrev_202106_26151",
      "26151"
    ],
    "Journal": {
      "ISSN": "2284-0729",
      "JournalIssue": {
        "Volume": "25",
        "Issue": "12",
        "PubDate": {
          "Year": "2021",
          "Month": "Jun"
        }
      },
      "Title": "European review for medical and pharmacological sciences",
      "ISOAbbreviation": "Eur Rev Med Pharmacol Sci"
    },
    "ArticleTitle": "Evolving biothreat of variant SARS-CoV-2 - molecular properties, virulence and epidemiology.",
    "Pagination": {
      "StartPage": "4405",
      "EndPage": "4412",
      "MedlinePgn": "4405-4412"
    },
    "Abstract": {
      "AbstractText": [
        "SARS-CoV-2 are enveloped RNA viruses that belong to the family Coronaviridae of genus Beta coronavirus, responsible for the COVID-19 pandemic. The mutation rate is high among RNA viruses and in particular, coronavirus replication is error prone with an estimated mutation rate of 4x10-4 nucleotide substitutions per site per year. Variants of SARS-CoV-2 have been reported from various countries like United Kingdom, South Africa, Denmark, Brazil and India. These variants evolved due to mutations in spike gene of SARS-CoV-2. The most concerning variants are Variant of Concern (VOC) 202012/01 from United Kingdom and B.1.617 variant of India. Other variants include B.1.351 lineages, cluster 5/SARS-CoV-2 variant of Denmark, 501.V2 variant/SARS-CoV-2 variant of South Africa, lineage B.1.1.248/lineage P.1 of Brazil. Mutations in S protein may result in changes in the transmissibility and virulence of SARS-CoV-2. To date, alterations in virulence or pathogenicity have been reported among the variants from many parts of the globe. In our opinion, since the S protein is significantly altered, the suitability of existing vaccine specifically targeting the S protein of SARS-CoV-2 variants is a major concern. The mutations in SARS-CoV-2 are a continuous and evolving process that may result in the transformation of na\u00efve SARS-CoV-2 into totally new subsets of antigenically different SARS-CoV-2 viruses over a period of time."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "School of Medicine, The Maldives National University Male, Maldives. Kannan.subbaram@mnu.edu.mv."
          }
        ],
        "LastName": "Kannan",
        "ForeName": "S",
        "Initials": "S"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Shaik Syed Ali",
        "ForeName": "P",
        "Initials": "P"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Sheeza",
        "ForeName": "A",
        "Initials": "A"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Italy",
    "MedlineTA": "Eur Rev Med Pharmacol Sci",
    "NlmUniqueID": "9717360",
    "ISSNLinking": "1128-3602"
  },
  "MeshHeadingList": [
    {
      "QualifierName": [
        "epidemiology",
        "genetics",
        "transmission"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "epidemiology"
      ],
      "DescriptorName": "India"
    },
    {
      "QualifierName": [
        "genetics"
      ],
      "DescriptorName": "Mutation"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Protein Structure, Secondary"
    },
    {
      "QualifierName": [
        "chemistry",
        "genetics",
        "pathogenicity"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [
        "epidemiology"
      ],
      "DescriptorName": "United Kingdom"
    },
    {
      "QualifierName": [
        "genetics"
      ],
      "DescriptorName": "Virulence"
    }
  ]
}